The company said it expects to deliver growth in the late twenties during the March quarter, driven by strong performance across its portfolio. On a reported basis, adjusting for changes in revenue recognition, growth is expected to be in the early twenties.

Its flagship brand Mamaearth is expected to post growth in the teens, continuing its steady trajectory supported by improving brand strength. Meanwhile, younger brands such as The Derma Co., Aqualogica, BBlunt, Dr. Sheth's, Staze and Luminive are expected to deliver growth in the mid-twenties, indicating broad-based traction across emerging segments.

The company also highlighted that its offline channel remains a key growth driver, with general trade and modern trade expected to continue strong momentum, aided by expanding distribution.

Honasa further stated that it expects to sustain its overall operating profit margin profile in Q4 FY26, supported by operating leverage in marketing spends and fixed overheads.

The update also marks the first full quarter of consolidation of BTM Ventures Private Limited, the parent of brands like The Derma Co. and Dr. Sheth's, which is expected to contribute positively to performance.

Following the update, shares of Honasa Consumer were trading at ₹335.60, up ₹22.20 or 7.08% on the NSE. The stock hit an intraday high of ₹348.65 and a low of ₹316.60, with volumes at 25,58,693 shares.

The strong Q4 update reinforces the company's consistent growth trajectory, marking its third consecutive quarter of solid performance.